Expression and impact on prognosis of plasma Copeptin, Galectin-3, NGAL in patients with heart failure

Expression and impact on prognosis of plasma Copeptin, Galectin-3, NGAL in patients with heart failu

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-14004873

Enrollment

Unknown

Registered

2014-06-24

Start date

2014-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

case series:N/A

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hospitalized patients for heart failure and the NYHA heart function classification at I to IV

Exclusion criteria

Exclusion criteria: Younger than 18 years, a history of chronic renal failure

Design outcomes

Primary

Measure	Time frame
Copeptin;Galectin-3;NGA;	—

Contacts

Public ContactShaozhong Liu

ls67890@sina.com+86 056 62816204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026